Stefan Frentzel
Philip Morris International (Switzerland)(CH)
Publications by Year
Research Areas
Inhalation and Respiratory Drug Delivery, Air Quality and Health Impacts, Molecular Biology Techniques and Applications, Carcinogens and Genotoxicity Assessment, Smoking Behavior and Cessation
Most-Cited Works
- → Subunit of the '20S' proteasome (multicatalytic proteinase) encoded by the major histocompatibility complex(1991)263 cited
- → Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS(2002)248 cited
- → Anti—Nogo-A Antibody Infusion 24 Hours after Experimental Stroke Improved Behavioral Outcome and Corticospinal Plasticity in Normotensive and Spontaneously Hypertensive Rats(2003)205 cited
- → A lung/liver-on-a-chip platform for acute and chronic toxicity studies(2018)180 cited
- → Altered chromatin architecture underlies progressive impairment of the heat shock response in mouse models of Huntington disease(2011)175 cited
- → Incorporation of major histocompatibility complex – encoded subunits LMP2 and LMP7 changes the quality of the 20S proteasome polypeptide processing products independent of interferon‐γ(1995)165 cited
- → 20 S proteasomes are assembled via distinct precursor complexes processing of LMP2 and LMP7 proproteins takes place in 13–16 S preproteasome complexes(1994)146 cited
- → Cultured rat microglia express functional β-chemokine receptors(1999)119 cited
- → Human multi-organ chip co-culture of bronchial lung culture and liver spheroids for substance exposure studies(2020)113 cited
- → The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2 mouse model of Huntington's disease(2010)96 cited